Novartis | NVS - Eigenkapital Und Reserven

Aktienkurs
146.93
Täglich Wechseln
-1.05 -0.71%
Monatlich
-4.56%
Jährlich
28.51%
Q2 Prognose
142.62




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bausch Health Companies USD -2.06B 1.5B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Canopy Growth CAD 758.17M 22.16M 2025-12
Corcept Therapeutics USD 637.99M 9.82M 2026-03
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Glaxosmithkline GBP 22.06B 360M 2025-12
J&J USD 81.19B 358M 2026-03
Merck USD 52.61B 756M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Sanofi EUR 71.71B 14.25B 2025-12
Supernus Pharmaceuticals USD 1.06B 12.05M 2025-12
Zoetis USD 3.33B 2.07B 2025-12